Banque Cantonale Vaudoise Co Diagnostics, Inc. Transaction History
Banque Cantonale Vaudoise
- $2.43 Billion
- Q3 2024
A detailed history of Banque Cantonale Vaudoise transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 180 shares of CODX stock, worth $124. This represents 0.0% of its overall portfolio holdings.
Number of Shares
180
Previous 180
-0.0%
Holding current value
$124
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CODX
# of Institutions
46Shares Held
5.61MCall Options Held
78.2KPut Options Held
119K-
Vanguard Group Inc Valley Forge, PA1.78MShares$1.23 Million0.0% of portfolio
-
Private Advisory Group LLC Redmond, WA1.18MShares$815,3260.1% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny556KShares$383,3790.0% of portfolio
-
Black Rock Inc. New York, NY502KShares$346,3970.0% of portfolio
-
Geode Capital Management, LLC Boston, MA346KShares$238,4020.0% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $23.3M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...